Nearly 4,000 physicians, scientists, pharmacists and technologists are expected to meet in New Orleans this week, starting on Saturday when the Society of Nuclear Medicine (SNM) convenes its 55th Annual Meeting at the Ernest N. Morial Convention Center. More than 1,600 scientific, technologist and technologist-student abstracts will be presented featuring the latest research in molecular imaging and nuclear medicine.
New featured events this year include the Joint SNM/U.S. Pharmacopoeia Symposium on Saturday from 8 am–4 pm; an NCI Workshop titled “Use of PET/CT in the Clinic and Clinical Trials,” organized by the National Cancer Institute, on Saturday from 8 am–4 pm; and Novel Approaches to Molecular Imaging. Investigators will present new scientific research in molecular imaging, including sessions on non-radioactive molecular imaging agents, techniques and multi-modality approaches.
Other highlighted events include:
Sunday, June 15th
- 8:30-10 am: Henry Wagner Lectureship—“Personalized Therapies: Opportunities and Challenges for Nuclear Medicine,” by Richard L. Wahl, MD, director of nuclear medicine/PET and vice chair of radiology for new technology and business development at Johns Hopkins School of Medicine.
- 10 am–7:30 pm: Molecular Imaging Gateway (Open Saturday through Tuesday)—features new technologies and applications of molecular imaging.
- 10 am–5 pm: Info SNM (Open every day of the conference)—Interactive computer presentations and educational sessions on the novel applications of computers and information science in molecular imaging and nuclear medicine will be on display.
Monday, June 16th
- 8:00–9:30 am: Cassen Lectureship—In his lecture “Genomic Biomarkers for Molecular Imaging: Predicting the Future,” Mathew L. Thakur, PhD, will discuss advances in genomics and proteomics that are shedding new light on the genesis of many diseases. As a result, molecular imaging is poised to play a pivotal role in the management of diseases and health.
Tuesday, June 17th
6:30 am-8am: “Gaining Clinical Utility: Insights into SPECT*CT,” an educational breakfast symposium sponsored by Molecular Imaging Insight magazine featuring sessions by Homer Macapinlac, MD, of MD Anderson Cancer Center; Frank Bengel, MD, of Johns Hopkins; and Brad Hellwig of Crouse Hospital, at the Hilton New Orleans Riverside, Grand Ballroom A. (SNM badge required.)
- 11:30 am–12 pm: SNM’s incoming president, Robert W. Atcher, PhD, will discuss his vision for SNM and the future of nuclear medicine and molecular imaging.
Wednesday, June 18th
- 11:30 am–1 pm: Highlights Lecture, summarizing current trends in molecular imaging and nuclear medicine by Henry H. Wagner Jr., Johns Hopkins University.
On the exhibit show floor, a variety of new products and enhancements are debuting and being featured. Here is a preview.
Advanced Medical Isotope Corporation (Booth 221) is highlighting its initiation of Fluorine-18 production, a first in a series of isotopes that AMIC has begun manufacturing at its Kennewick, Wash.-based production facility. The company is utilizing its compact linear accelerator designed for the production of medical isotopes used in PET imaging, as well as featuring other diagnostic and therapeutic medical isotopes.
Capintec (Booth 1355) is unveiling two new products at SNM—Captus 3000 Emergency Population Screening System (Captus 3000 EPSS) and CapIMAGE Small Field of View Gamma Camera System.
CapIMAGE, designed for imaging small organs and body parts including the thyroid, parathyroid, extremities and gated cardiac studies, provides a small footprint with a highly versatile detector. The system also allows detailed images with rapid acquisition, processing and data storage via DICOM connectivity.
The Captus 3000 EPSS combines Capintec’s Captus 3000 Thyroid Uptake system with software designed for rapid emergency population screening and quantification of internal organ contamination associated with a radiologic event. The light, portable stand easily folds for transport. The Captus 3000 protocol module allows users to develop customized measurement and calculation protocols using predefined Captus 3000 input, measurement and report screens that are integrated with Excel spreadsheet functions.
Covidien (Booth 1055) is featuring its Octreoscan kit for the preparation of Indium (In-111) pentetreotide, a molecular imaging agent for the scintigraphic localization of primary and metastatic neuroendocrine tumors bearing somatostatin receptors.